Benzinga's Top #PreMarket Gainers

Amicus Therapeutics

shares jumped 46.74% to $2.70 in pre-market trading after the company reported positive 12- and 24-month data from Phase 3 Fabry monotherapy study 011. Novavax

shares gained 10.41% to $4.35 in pre-market trading after the company reported positive top-line data from dose-confirmatory Phase 2 clinical trial of its RSV vaccine candidate. Central European Media Enterprises

soared 7.51% to $2.72 in the pre-market trading on a report that three Czech businessmen including billionaire Petr Kellner are in talks to acquire the company. Cubist Pharmaceuticals

surged 5.92% to $66.00 in the pre-market session amid renewed takeover chatter.